Habibeh Mashayekhi-Sardoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Habibeh Mashayekhi-Sardoo has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Yousef Baghcheghi
Bio Environmental Health Hazards Research Center, Jiroft University of Medical Sciences, Jiroft, Iran
5 shared publications - Mahdiyeh Hedayati-Moghadam
Department of Physiology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran
4 shared publications - Amir Hooshang Mohammadpour
Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publications - Amirhossein Sahebkar
Mashhad University of Medical Sciences
3 shared publications - Gholamreza Karimi
Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publications Hedyeh Askarpour
Student Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran
2 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by The Nencki Institute of Experimental Biology, Polish Academy of Sciences in Acta Neurobiologiae Experimentalis
Molecular mechanisms of coffee’s antidepressant effects in chronic consumption: A context‑dependent perspective
Coffee, one of the most widely consumed beverages, is associated with reduced depression risk in epidemiological studies. However, the relationship between coffee consumption and mental health is more nuanced than a simple antidepressant effect. This review critically examines the molecular mechanisms by which chronic coffee consumption may influence mood, while emphasizing that these effects depend on dose, timing, genetic variability, metabolic status, sleep, and behavioral context. Key bioactive compounds in coffee—including caffeine, chlorogenic acids, trigonelline, and polyphenols—exert effects through adenosine receptor antagonism, monoamine, anti‑inflammatory actions, brain‑derived neurotrophic factor signaling activation, oxidative stress reduction, hypothalamic‑pituitary‑adrenal axis modulation, gut‑brain axis communication, and metabolic pathway regulation. Importantly, this review distinguishes between coffee‑specific effects and those attributable to caffeine alone, recognizing that coffee contains numerous bioactive compounds beyond caffeine that may contribute to its overall biological activity. The review also critically addresses potential adverse effects, including sleep disruption, anxiety exacerbation, and maladaptive coping patterns, particularly in vulnerable populations such as students, shift workers, and individuals with pre‑existing anxiety disorders. Genetic polymorphisms in CYP1A2 and ADORA2A are discussed as important moderators of caffeine metabolism and sensitivity. The review concludes that while moderate coffee consumption may offer mood‑related benefits under certain conditions, these effects should be interpreted within a conditional risk‑benefit framework rather than as a universal antidepressant property.
- 13 November 2026
- Published by The Nencki Institute of Experimental Biology, Polish Academy of Sciences in Acta Neurobiologiae Experimentalis
Open AccessMolecular mechanisms of coffee’s antidepressant effects in chronic consumption: A context‑dependent perspective
Coffee, one of the most widely consumed beverages, is associated with reduced depression risk in epidemiological studies. However, the relationship between coffee consumption and mental health is more nuanced than a simple antidepressant effect. This review critically examines the molecular mechanisms by which chronic coffee consumption may influence mood, while emphasizing that these effects depend on dose, timing, genetic variability, metabolic status, sleep, and behavioral context. Key bioactive compounds in coffee—including caffeine, chlorogenic acids, trigonelline, and polyphenols—exert effects through adenosine receptor antagonism, monoamine, anti‑inflammatory actions, brain‑derived neurotrophic factor signaling activation, oxidative stress reduction, hypothalamic‑pituitary‑adrenal axis modulation, gut‑brain axis communication, and metabolic pathway regulation. Importantly, this review distinguishes between coffee‑specific effects and those attributable to caffeine alone, recognizing that coffee contains numerous bioactive compounds beyond caffeine that may contribute to its overall biological activity. The review also critically addresses potential adverse effects, including sleep disruption, anxiety exacerbation, and maladaptive coping patterns, particularly in vulnerable populations such as students, shift workers, and individuals with pre‑existing anxiety disorders. Genetic polymorphisms in CYP1A2 and ADORA2A are discussed as important moderators of caffeine metabolism and sensitivity. The review concludes that while moderate coffee consumption may offer mood‑related benefits under certain conditions, these effects should be interpreted within a conditional risk‑benefit framework rather than as a universal antidepressant property.
- 1 May 2026
- Published by Springer Nature in Psychopharmacology
- p. 1-48
Memory impairment and chronic high-dose Δ9-THC/cannabis exposure: a narrative review of molecular mechanisms underlying neurotoxic effects
Rationale The increasing potency of cannabis and the growing prevalence of chronic, high-dose use have raised concerns about its potential neurotoxic effects on cognitive functions, particularly memory. While low-dose cannabinoids have demonstrated therapeutic benefits, the molecular basis of memory impairment under high-dose exposure remains insufficiently clarified. Objectives This narrative review aims to elucidate the molecular mechanisms underlying memory impairment associated with chronic, high-dose Δ9-tetrahydrocannabinol (Δ9-THC) and cannabis exposure, and to distinguish these effects from the beneficial outcomes observed at lower doses. Methods A narrative review methodology was employed to synthesize evidence from both human studies and murine models, focusing on molecular, cellular, and neurobiological pathways involved in memory dysfunction. Results Chronic high-dose activation of the endocannabinoid system (ECS) induces acascade of adverse molecular events, including neuroinflammation, oxidative stress, and activation of apoptotic pathways. Significant dysregulation of key neurotransmitter systems was also observed. Importantly, high-dose Δ9-THC disrupts neuroplasticity by impairing hippocampal neurogenesis, synaptogenesis, and dendritic remodeling, thereby compromising mechanisms essential for memory formation and consolidation. Adolescents and elderly individuals were identified as particularly vulnerable populations. Conclusions Chronic exposure to highdose Δ9-THC is strongly associated with memory impairment through interconnected molecular pathways. These findings provide a mechanistic framework linking cannabis exposure to cognitive deficits and highlight the need for longitudinal human studies and the development of targeted therapeutic interventions. Graphical Abstract This graphical abstract synthesizes the core molecular and cellular mechanisms through which chronic, high-dose Δ9-tetrahydrocannabinol (THC) exposure leads to memory impairment. Sustained overstimulation of the endocannabinoid system, particularly via presynaptic cannabinoid type 1 (CB1) receptors, initiates a cascade of adverse events in the hippocampus and related memory circuits. The illustrated pathways include: 1. Neuroinflammation: Microglial activation and release of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6). 2. Oxidative Stress & Mitochondrial Dysfunction: Increased reactive oxygen species (ROS) production, lipid peroxidation, and disruption of cellular antioxidant defenses. 3. Apoptotic Signaling: Induction of endoplasmic reticulum stress, mitochondrial outer membrane permeabilization (MOMP), and activation of caspase-dependent neuronal death pathways. 4. Neurotransmitter Dysregulation: Disruption of the critical balance between glutamate and GABA, impairing synaptic plasticity essential for learning and memory. 5. Impaired Neuroplasticity: Suppression of hippocampal neurogenesis, reduced synaptogenesis, dendritic remodeling, and spine loss. 6. Disruption of Neurotrophic Support: Altered brain-derived neurotrophic factor (BDNF) signaling, compromising neuronal health and synaptic integrity. These interconnected mechanisms converge to disrupt long-term potentiation (LTP), degrade the structural integrity of hippocampal networks, and ultimately manifest as deficits in memory formation, consolidation, and retrieval. The alternative text for this image may have been generated using AI.
- 1 May 2026
- Published by Springer Nature in Psychopharmacology
- p. 1-48
Memory impairment and chronic high-dose Δ9-THC/cannabis exposure: a narrative review of molecular mechanisms underlying neurotoxic effects
Rationale The increasing potency of cannabis and the growing prevalence of chronic, high-dose use have raised concerns about its potential neurotoxic effects on cognitive functions, particularly memory. While low-dose cannabinoids have demonstrated therapeutic benefits, the molecular basis of memory impairment under high-dose exposure remains insufficiently clarified. Objectives This narrative review aims to elucidate the molecular mechanisms underlying memory impairment associated with chronic, high-dose Δ9-tetrahydrocannabinol (Δ9-THC) and cannabis exposure, and to distinguish these effects from the beneficial outcomes observed at lower doses. Methods A narrative review methodology was employed to synthesize evidence from both human studies and murine models, focusing on molecular, cellular, and neurobiological pathways involved in memory dysfunction. Results Chronic high-dose activation of the endocannabinoid system (ECS) induces acascade of adverse molecular events, including neuroinflammation, oxidative stress, and activation of apoptotic pathways. Significant dysregulation of key neurotransmitter systems was also observed. Importantly, high-dose Δ9-THC disrupts neuroplasticity by impairing hippocampal neurogenesis, synaptogenesis, and dendritic remodeling, thereby compromising mechanisms essential for memory formation and consolidation. Adolescents and elderly individuals were identified as particularly vulnerable populations. Conclusions Chronic exposure to highdose Δ9-THC is strongly associated with memory impairment through interconnected molecular pathways. These findings provide a mechanistic framework linking cannabis exposure to cognitive deficits and highlight the need for longitudinal human studies and the development of targeted therapeutic interventions. Graphical Abstract This graphical abstract synthesizes the core molecular and cellular mechanisms through which chronic, high-dose Δ9-tetrahydrocannabinol (THC) exposure leads to memory impairment. Sustained overstimulation of the endocannabinoid system, particularly via presynaptic cannabinoid type 1 (CB1) receptors, initiates a cascade of adverse events in the hippocampus and related memory circuits. The illustrated pathways include: 1. Neuroinflammation: Microglial activation and release of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6). 2. Oxidative Stress & Mitochondrial Dysfunction: Increased reactive oxygen species (ROS) production, lipid peroxidation, and disruption of cellular antioxidant defenses. 3. Apoptotic Signaling: Induction of endoplasmic reticulum stress, mitochondrial outer membrane permeabilization (MOMP), and activation of caspase-dependent neuronal death pathways. 4. Neurotransmitter Dysregulation: Disruption of the critical balance between glutamate and GABA, impairing synaptic plasticity essential for learning and memory. 5. Impaired Neuroplasticity: Suppression of hippocampal neurogenesis, reduced synaptogenesis, dendritic remodeling, and spine loss. 6. Disruption of Neurotrophic Support: Altered brain-derived neurotrophic factor (BDNF) signaling, compromising neuronal health and synaptic integrity. These interconnected mechanisms converge to disrupt long-term potentiation (LTP), degrade the structural integrity of hippocampal networks, and ultimately manifest as deficits in memory formation, consolidation, and retrieval. The alternative text for this image may have been generated using AI.
- Open Access
- 21 April 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (4)
Molecular Pathogenesis of Memory Impairment in Parkinson's Disease: An Exploration of Underlying Mechanisms
Background and Aim: Parkinson's disease (PD) is primarily known for its motor symptoms but is increasingly recognized for its substantial cognitive effects, particularly on memory. This narrative review aims to clarify the complex molecular mechanisms contributing to memory impairment in PD by integrating findings from both animal and clinical research. Methods: This study is a narrative review synthesizing data from existing literature. It begins by addressing the prevalence of cognitive deficits among PD patients. It then explores animal studies investigating pathophysiological changes associated with PD, focusing on the impact of dopaminergic depletion on neural circuitry. These findings are integrated with clinical research to identify specific molecular changes closely associated with memory impairment independent of motor dysfunction. Results: The review systematically examines key molecular mechanisms contributing to memory deficits in PD. These mechanisms include disruptions in neural circuits, dopamine depletion, neuroinflammation, oxidative stress, and alpha‐synuclein pathology. Additional contributing factors identified include cholinergic system dysfunction, cortical thinning and atrophy, disrupted neural oscillations, gut‐brain axis dysfunction, impaired synaptic plasticity, and alterations in neurotransmitter systems. The analysis illustrates how these factors collectively undermine cognitive function. Conclusion: By synthesizing insights from various studies, this narrative review offers a comprehensive perspective on the intricate molecular pathogenesis of memory impairment in PD. It underscores the necessity of addressing both motor and non‐motor symptoms in managing PD effectively and advocates for a holistic treatment approach that considers cognitive decline alongside traditional motor symptom management.
- 21 April 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (4)
Open AccessMolecular Pathogenesis of Memory Impairment in Parkinson's Disease: An Exploration of Underlying Mechanisms
Background and Aim: Parkinson's disease (PD) is primarily known for its motor symptoms but is increasingly recognized for its substantial cognitive effects, particularly on memory. This narrative review aims to clarify the complex molecular mechanisms contributing to memory impairment in PD by integrating findings from both animal and clinical research. Methods: This study is a narrative review synthesizing data from existing literature. It begins by addressing the prevalence of cognitive deficits among PD patients. It then explores animal studies investigating pathophysiological changes associated with PD, focusing on the impact of dopaminergic depletion on neural circuitry. These findings are integrated with clinical research to identify specific molecular changes closely associated with memory impairment independent of motor dysfunction. Results: The review systematically examines key molecular mechanisms contributing to memory deficits in PD. These mechanisms include disruptions in neural circuits, dopamine depletion, neuroinflammation, oxidative stress, and alpha‐synuclein pathology. Additional contributing factors identified include cholinergic system dysfunction, cortical thinning and atrophy, disrupted neural oscillations, gut‐brain axis dysfunction, impaired synaptic plasticity, and alterations in neurotransmitter systems. The analysis illustrates how these factors collectively undermine cognitive function. Conclusion: By synthesizing insights from various studies, this narrative review offers a comprehensive perspective on the intricate molecular pathogenesis of memory impairment in PD. It underscores the necessity of addressing both motor and non‐motor symptoms in managing PD effectively and advocates for a holistic treatment approach that considers cognitive decline alongside traditional motor symptom management.
- 4 February 2026
- Published by Elsevier in Journal of Pediatric Health Care
- Vol. 40 (5) , e207-e214
Fenofibrate vs. Omega-3 in Pediatric Hypertriglyceridemia: A Randomized Controlled Trial
- 4 February 2026
- Published by Elsevier in Journal of Pediatric Health Care
- Vol. 40 (5) , e207-e214
Fenofibrate vs. Omega-3 in Pediatric Hypertriglyceridemia: A Randomized Controlled Trial
- Open Access
- 6 January 2026
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 10
Unraveling the molecular links: Alzheimer's disease-induced mechanisms of memory impairment: A narrative review
Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive memory impairment and cognitive decline, significantly impacting the quality of life for millions worldwide. Understanding the intricate molecular pathways linking AD pathology to memory dysfunction is crucial for developing effective therapies. This narrative review aims to elucidate the key molecular mechanisms underlying memory impairment in AD. We conducted a comprehensive literature search across major scientific databases (e.g., PubMed, Scopus, Web of Science) focusing on peer-reviewed studies (original research, reviews) exploring the molecular links between AD pathology and memory deficits. The review identifies and details several interconnected molecular pathways driving memory impairment in AD: (1) Synaptic dysfunction and neuronal loss triggered by amyloid-β (Aβ) peptide accumulation and aggregation; (2) Intracellular transport disruption and neurodegeneration caused by tau protein hyperphosphorylation and aggregation; (3) Exacerbation of cognitive deficits by neuroinflammation, mediated through activated microglia and pro-inflammatory cytokines (e.g., IL-1β, TNF-α, IL-6); (4) Impairment of synaptic plasticity and cognitive function due to dysregulation of neurotrophic factors, particularly brain-derived neurotrophic factor; (5) Contributory roles of oxidative stress, mitochondrial dysfunction, disrupted neurotransmission (e.g., acetylcholine, GABA), and apoptotic pathways. This review comprehensively unravels the critical molecular links between AD pathology and memory impairment, emphasizing the interplay of Aβ, tau, neuroinflammation, neurotrophic factor dysregulation, and other mechanisms. Targeting these interconnected pathways represents a promising strategic approach for developing therapies to mitigate cognitive decline and improve outcomes in AD patients.
- 6 January 2026
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 10
Open AccessUnraveling the molecular links: Alzheimer's disease-induced mechanisms of memory impairment: A narrative review
Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive memory impairment and cognitive decline, significantly impacting the quality of life for millions worldwide. Understanding the intricate molecular pathways linking AD pathology to memory dysfunction is crucial for developing effective therapies. This narrative review aims to elucidate the key molecular mechanisms underlying memory impairment in AD. We conducted a comprehensive literature search across major scientific databases (e.g., PubMed, Scopus, Web of Science) focusing on peer-reviewed studies (original research, reviews) exploring the molecular links between AD pathology and memory deficits. The review identifies and details several interconnected molecular pathways driving memory impairment in AD: (1) Synaptic dysfunction and neuronal loss triggered by amyloid-β (Aβ) peptide accumulation and aggregation; (2) Intracellular transport disruption and neurodegeneration caused by tau protein hyperphosphorylation and aggregation; (3) Exacerbation of cognitive deficits by neuroinflammation, mediated through activated microglia and pro-inflammatory cytokines (e.g., IL-1β, TNF-α, IL-6); (4) Impairment of synaptic plasticity and cognitive function due to dysregulation of neurotrophic factors, particularly brain-derived neurotrophic factor; (5) Contributory roles of oxidative stress, mitochondrial dysfunction, disrupted neurotransmission (e.g., acetylcholine, GABA), and apoptotic pathways. This review comprehensively unravels the critical molecular links between AD pathology and memory impairment, emphasizing the interplay of Aβ, tau, neuroinflammation, neurotrophic factor dysregulation, and other mechanisms. Targeting these interconnected pathways represents a promising strategic approach for developing therapies to mitigate cognitive decline and improve outcomes in AD patients.
- 29 September 2025
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 36 (1) , 29-64
Radioprotection or radiosensitization? Unraveling caffeine’s bifurcated effects on radiation-induced damage
Caffeine, a widely consumed phytochemical, exhibits a dual and paradoxical role in modulating cellular responses to radiation, acting as both a radioprotector and radiosensitizer depending on context. This comprehensive review synthesizes evidence from in vitro, in vivo, and clinical studies to elucidate caffeine's multifaceted interactions with ionizing (gamma rays, X-rays) and non-ionizing (UV) radiation. Mechanistically, caffeine influences DNA repair pathways-notably inhibiting ATM/ATR checkpoint kinases-overrides G2/M cell cycle arrest, and modulates apoptosis through p53-dependent and independent pathways. While caffeine demonstrates radioprotective potential by mitigating oxidative stress, enhancing antioxidant defenses, and reducing chromosomal aberrations in normal tissues, it concurrently sensitizes cancer cells to radiation by disrupting DNA repair and amplifying mitotic catastrophe. Intriguingly, its effects vary by radiation type, dose, cell lineage (e.g. p53 status), and administration timing, underscoring its context-dependent utility. Preclinical studies highlight caffeine's capacity to attenuate radiation-induced hepatotoxicity, skin damage, and cataract formation, yet caution is warranted due to risks of exacerbating chromosomal instability and teratogenicity. Clinically, retrospective data suggest caffeine may reduce late radiotherapy toxicity in cervical cancer patients, though evidence remains sparse. This review underscores caffeine's potential as an adjuvant in radiotherapy but emphasizes the necessity for precision in its application, balancing therapeutic benefits against risks. Further research is critical to unravel dose-response dynamics, optimize timing, and validate clinical translatability across diverse radiation modalities.
- 29 September 2025
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 36 (1) , 29-64
Radioprotection or radiosensitization? Unraveling caffeine’s bifurcated effects on radiation-induced damage
Caffeine, a widely consumed phytochemical, exhibits a dual and paradoxical role in modulating cellular responses to radiation, acting as both a radioprotector and radiosensitizer depending on context. This comprehensive review synthesizes evidence from in vitro, in vivo, and clinical studies to elucidate caffeine's multifaceted interactions with ionizing (gamma rays, X-rays) and non-ionizing (UV) radiation. Mechanistically, caffeine influences DNA repair pathways-notably inhibiting ATM/ATR checkpoint kinases-overrides G2/M cell cycle arrest, and modulates apoptosis through p53-dependent and independent pathways. While caffeine demonstrates radioprotective potential by mitigating oxidative stress, enhancing antioxidant defenses, and reducing chromosomal aberrations in normal tissues, it concurrently sensitizes cancer cells to radiation by disrupting DNA repair and amplifying mitotic catastrophe. Intriguingly, its effects vary by radiation type, dose, cell lineage (e.g. p53 status), and administration timing, underscoring its context-dependent utility. Preclinical studies highlight caffeine's capacity to attenuate radiation-induced hepatotoxicity, skin damage, and cataract formation, yet caution is warranted due to risks of exacerbating chromosomal instability and teratogenicity. Clinically, retrospective data suggest caffeine may reduce late radiotherapy toxicity in cervical cancer patients, though evidence remains sparse. This review underscores caffeine's potential as an adjuvant in radiotherapy but emphasizes the necessity for precision in its application, balancing therapeutic benefits against risks. Further research is critical to unravel dose-response dynamics, optimize timing, and validate clinical translatability across diverse radiation modalities.
- 27 June 2025
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 203, 115612
Evaluation of pesticide residues in greenhouse workers' blood serum using QuEChERS-UHPLC-MS/MS method and associated health risks
- 27 June 2025
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 203, 115612
Evaluation of pesticide residues in greenhouse workers' blood serum using QuEChERS-UHPLC-MS/MS method and associated health risks
- Open Access
- 22 May 2025
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 45 (1) , 49
Ethanol-Induced Depression: Exploring the Underlying Molecular Mechanisms
Ethanol consumption is widely recognized for its detrimental effects on mental health, particularly its association with depressive disorders. This narrative review aims to explore the intricate molecular mechanisms underlying ethanol-induced depression, synthesizing findings from preclinical and clinical studies. We begin by providing an overview of the relationship between chronic ethanol consumption and depression, highlighting compelling evidence from diverse populations. Subsequently, we delve into insights from animal models that elucidate the pathophysiological changes triggered by prolonged ethanol exposure. Key mechanisms identified include oxidative stress, which contributes to cellular damage; neuroinflammation, characterized by the activation of glial cells and altered cytokine profiles; and disruptions in neurotrophic factors that impair neuronal growth and survival. Furthermore, we discuss the induction of apoptosis in neural cells and the significant impact of ethanol on neurotransmitter receptor remodeling and regulation, leading to altered synaptic transmission. While substantial progress has been made in understanding these mechanisms, we also acknowledge the limitations of current research methodologies and call for further investigations to translate these findings into effective therapeutic strategies for individuals affected by ethanol-induced depression. This review ultimately underscores the need for a comprehensive understanding of the molecular underpinnings of ethanol's impact on mood disorders, paving the way for improved interventions and preventative measures.
- 22 May 2025
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 45 (1) , 49
Open AccessEthanol-Induced Depression: Exploring the Underlying Molecular Mechanisms
Ethanol consumption is widely recognized for its detrimental effects on mental health, particularly its association with depressive disorders. This narrative review aims to explore the intricate molecular mechanisms underlying ethanol-induced depression, synthesizing findings from preclinical and clinical studies. We begin by providing an overview of the relationship between chronic ethanol consumption and depression, highlighting compelling evidence from diverse populations. Subsequently, we delve into insights from animal models that elucidate the pathophysiological changes triggered by prolonged ethanol exposure. Key mechanisms identified include oxidative stress, which contributes to cellular damage; neuroinflammation, characterized by the activation of glial cells and altered cytokine profiles; and disruptions in neurotrophic factors that impair neuronal growth and survival. Furthermore, we discuss the induction of apoptosis in neural cells and the significant impact of ethanol on neurotransmitter receptor remodeling and regulation, leading to altered synaptic transmission. While substantial progress has been made in understanding these mechanisms, we also acknowledge the limitations of current research methodologies and call for further investigations to translate these findings into effective therapeutic strategies for individuals affected by ethanol-induced depression. This review ultimately underscores the need for a comprehensive understanding of the molecular underpinnings of ethanol's impact on mood disorders, paving the way for improved interventions and preventative measures.
- 20 May 2025
- Published by Elsevier in Cancer Epidemiology
- Vol. 97, 102840
The clinical relevance of microplastic exposure on colorectal cancer: A systematic review
- 20 May 2025
- Published by Elsevier in Cancer Epidemiology
- Vol. 97, 102840
The clinical relevance of microplastic exposure on colorectal cancer: A systematic review
- Open Access
- 13 May 2025
- Published by Elsevier in Virus Research
- Vol. 357, 199585
The global prevalence of co-occurrence of Sjögren syndrome and Hepatitis C virus infection: A systematic review and meta-analysis
- 13 May 2025
- Published by Elsevier in Virus Research
- Vol. 357, 199585
Open AccessThe global prevalence of co-occurrence of Sjögren syndrome and Hepatitis C virus infection: A systematic review and meta-analysis